Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Shares of medical technology company Integer Holdings (NYSE:ITGR)
jumped 3.4% in the morning session after the company reported better-than-expected fourth-quarter 2025 results and provided an encouraging profit forecast for the upcoming year.
Medical technology company Integer Holdings (NYSE:ITGR) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 5% year on year to $472.1 million. The company expects the full year’s revenue to be around $1.85 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 3.6% above analysts’ consensus estimates.
Shares of medical technology company Integer Holdings (NYSE:ITGR)
jumped 4.2% in the morning session after the company reported better-than-expected fourth-quarter 2025 revenue and earnings, alongside encouraging profit guidance for the upcoming year. The medical device manufacturer's fourth-quarter revenue grew 5% year-over-year to $472.1 million, surpassing Wall Street's estimates. Its adjusted earnings per share (EPS) of $1.76 also beat expectations and marked a 23% increase from the same period in the prior year. Looking ahead, Integer provided an adjusted EPS forecast for 2026 with a midpoint of $6.54, which was 3.8% above analysts' projections. This strong profit outlook likely overshadowed a weaker forecast for flat revenue growth, giving investors reason for optimism.
Medical technology company Integer Holdings (NYSE:ITGR) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5% year on year to $472.1 million. The company expects the full year’s revenue to be around $1.85 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 3.6% above analysts’ consensus estimates.
What a brutal six months it’s been for Integer Holdings. The stock has dropped 23.1% and now trades at $85.78, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Integer Holdings Corp (ITGR) is a value stock with strong valuation metrics, solid profitability, and a stable financial position, indicating potential market undervaluation.
Looking back on medical devices & supplies - specialty stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Integer Holdings (NYSE:ITGR) and its peers.
